1470 related articles for article (PubMed ID: 15340416)
21. Interpreting cancer vaccine clinical trials.
Dranoff G
J Gene Med; 1999; 1(2):80-3. PubMed ID: 10738571
[TBL] [Abstract][Full Text] [Related]
22. [Immunological tumor therapy].
Dietrich K; Theobald M
Internist (Berl); 2015 Aug; 56(8):907-16; quiz 917. PubMed ID: 26187335
[TBL] [Abstract][Full Text] [Related]
23. Cancer-vaccine trials give reasons for optimism.
Drew L
Nature; 2024 Mar; 627(8005):S33. PubMed ID: 38538945
[No Abstract] [Full Text] [Related]
24. Cancer vaccines: preclinical studies and novel strategies.
Palena C; Abrams SI; Schlom J; Hodge JW
Adv Cancer Res; 2006; 95():115-45. PubMed ID: 16860657
[TBL] [Abstract][Full Text] [Related]
25. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
Fournier P; Schirrmacher V
Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
[TBL] [Abstract][Full Text] [Related]
26. Advances in strategies and methodologies in cancer immunotherapy.
Lam SS; Zhou F; Hode T; Nordquist RE; Alleruzzo L; Raker J; Chen WR
Discov Med; 2015 Apr; 19(105):293-301. PubMed ID: 25977192
[TBL] [Abstract][Full Text] [Related]
27. Cancer immunotherapy: moving forward with peptide T cell vaccines.
Kumai T; Fan A; Harabuchi Y; Celis E
Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
[TBL] [Abstract][Full Text] [Related]
28. Novel immunologic approaches to the management of malignant melanoma.
Weber JS; Aparicio A
Curr Opin Oncol; 2001 Mar; 13(2):124-8. PubMed ID: 11224710
[TBL] [Abstract][Full Text] [Related]
29. A new era in anticancer peptide vaccines.
Perez SA; von Hofe E; Kallinteris NL; Gritzapis AD; Peoples GE; Papamichail M; Baxevanis CN
Cancer; 2010 May; 116(9):2071-80. PubMed ID: 20187092
[TBL] [Abstract][Full Text] [Related]
30. [Immunotherapy: new insights].
Geissler M; Weth R
Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
[TBL] [Abstract][Full Text] [Related]
31. Next generation approaches for tumor vaccination.
Patel A; Kaufman HL; Disis ML
Chin Clin Oncol; 2017 Apr; 6(2):19. PubMed ID: 28482672
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic vaccines in solid tumours: can they be harmful?
Eggermont AM
Eur J Cancer; 2009 Aug; 45(12):2087-90. PubMed ID: 19477117
[TBL] [Abstract][Full Text] [Related]
33. Cancer vaccines.
Nakamura Y
Clin Adv Hematol Oncol; 2011 Oct; 9(10):778-9. PubMed ID: 22252581
[No Abstract] [Full Text] [Related]
34. [Personalized peptide vaccine for cancer treatment; now and its future].
Waki K; Yamada A
Nihon Rinsho; 2017 Feb; 75(2):251-256. PubMed ID: 30562860
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of T-cell inhibition: implications for cancer immunotherapy.
Mittendorf EA; Sharma P
Expert Rev Vaccines; 2010 Jan; 9(1):89-105. PubMed ID: 20021308
[TBL] [Abstract][Full Text] [Related]
36. Novel approaches in cancer immunotherapy.
Subramaniam DS; Liu SV; Giaccone G
Discov Med; 2016 Apr; 21(116):267-74. PubMed ID: 27232512
[TBL] [Abstract][Full Text] [Related]
37. [Development of next-generation peptide vaccination therapy].
Tsukahara T; Hirohashi Y; Emori M; Torigoe T
Nihon Rinsho; 2017 Feb; 75(2):270-274. PubMed ID: 30562863
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity.
Ressing ME; Offringa R; Toes RE; Ossendorp F; de Jong JH; Brandt RM; Kast WM; Melief CJ
Immunotechnology; 1996 Nov; 2(4):241-51. PubMed ID: 9373306
[TBL] [Abstract][Full Text] [Related]
39. Peptide vaccine.
Izumoto S
Adv Exp Med Biol; 2012; 746():166-77. PubMed ID: 22639167
[TBL] [Abstract][Full Text] [Related]
40. Antitumor vaccination using peptide based vaccines.
Eisenbach L; Bar-Haim E; El-Shami K
Immunol Lett; 2000 Sep; 74(1):27-34. PubMed ID: 10996624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
